Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam B Olshen

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Cell|November 1, 2011
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaElisa Oricchio, Gouri Nanjangud, Andrew L Wolfe, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Cancer Cell|September 17, 2015
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain TumorsTali Mazor, Aleksandr Pankov, Brett E Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian WomenValentina A Zavala, Sandro Casavilca-Zambrano, Jeannie Navarro-Vásquez, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.
BMC Genetics|February 7, 2008
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotypingAdam B Olshen, Bert Gold, Kirk E Lohmueller, et al.
Cell|November 1, 2011
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphomaElisa Oricchio, Gouri Nanjangud, Andrew L Wolfe, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Nature Genetics|September 8, 2015
Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathwayA Hunter Shain, Maria Garrido, Thomas Botton, et al.
Cancer Cell|September 17, 2015
DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain TumorsTali Mazor, Aleksandr Pankov, Brett E Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 2017
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>Tali Mazor, Charles Chesnelong, Aleksandr Pankov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian WomenValentina A Zavala, Sandro Casavilca-Zambrano, Jeannie Navarro-Vásquez, et al.
Blood|June 1, 2026
Dynamic genetic and nongenetic RAS pathway activation drives resistance to FLT3 and BCL2 inhibitor therapyVanessa E Kennedy, Cheryl A C Peretz, Anushka Walia, et al.
Pageof 10